EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.

JSON

Gustafsson H, Kale A, Dasu A, Lund A, Edqvist PH, Roberg K

Cell Biochem. Biophys. 75 (3-4) 299-309 [2017-12-00; online 2017-07-29]

Head and neck squamous cell carcinoma (HNSCC) tumours are associated with high mortality despite advances in therapy. The monoclonal antibody cetuximab (Erbitux

Affiliated researcher

PubMed 28756482

DOI 10.1007/s12013-017-0814-5

Crossref 10.1007/s12013-017-0814-5

pii: 10.1007/s12013-017-0814-5
pmc: PMC5691101